Stormont-Vail Regional Health Center
Topeka, Kansas, United States
Hospital department in Topeka, Kansas
1500 SW 10th Ave, Topeka, KS 66604
About Stormont-Vail Regional Health Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
8
SWOG Cancer Research Network
3
Alliance for Clinical Trials in Oncology
2
Pfizer
2
ECOG-ACRIN Cancer Research Group
1
NSABP Foundation Inc
1
Pediatrix
1
Seattle Children's Hospital
1
University of Kansas
1
University of Nebraska
1
Clinical Trials at Stormont-Vail Regional Health Center
During the past decade, Stormont-Vail Regional Health Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 8 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
2000-12-01
2014-11-01
Terminated
748
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2005-09-01
2015-04-01
Completed
1,873
Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
2007-08-01
2011-01-01
Completed
109
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
2007-06-01
2012-11-01
Terminated
72
Genetic Testing in Detection of Late-Onset Hearing Loss
2007-10-01
2011-09-01
Completed
3,681
Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
2007-11-01
2015-10-01
Terminated
96
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Stormont-Vail Regional Health Center" #1 sponsor was "National Cancer Institute (NCI)" with 8 trials, followed by "SWOG Cancer Research Network" with 3 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 2 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Stormont-Vail Regional Health Center"
#1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Stormont-Vail Regional Health Center
According to Clinical.Site data, the most researched conditions in "Stormont-Vail Regional Health Center" are
"Breast Cancer" (2 trials), "ADH Inappropriate" (1 trials), "Adenocarcinoma of the Colon" (1 trials), "Adenocarcinoma of the Rectum" (1 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "Stormont-Vail Regional Health Center" in a lesser frequency.
Clinical Trials Intervention Types at Stormont-Vail Regional Health Center
Most popular intervention types in "Stormont-Vail Regional Health Center" are "Drug" (16 trials), "Other" (10 trials), "Biological" (6 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Paclitaxel" (4 trials), "placebo" (4 trials), "Bevacizumab" (3 trials), "Carboplatin" (3 trials) and "Laboratory Biomarker Analysis" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Stormont-Vail Regional Health Center
The vast majority of trials in "Stormont-Vail Regional Health Center" are
18 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Stormont-Vail Regional Health Center
Currently, there are NaN active trials in "Stormont-Vail Regional Health Center".
undefined are not yet recruiting,
1 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Stormont-Vail Regional Health Center,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Stormont-Vail Regional Health Center, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 13 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 3 trials that are defined as “Not Applicable".
Departments of Stormont-Vail Regional Health Center
Stormont-Vail Regional Health Center has several departments that took part in Clinical trials: "Cotton O'Neil Cancer Center / Stormont Vail Health" - 159 trials, "Cotton-O'Neil Clinical Research Center, Hematology and Oncology" - 3 trials
Departments List
Name
City
Trials